Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Clinpro White Varnish** is a professionally applied, moisture- and saliva-activated topical dental varnish developed by 3M and currently marketed by Solventum. It contains 5% sodium fluoride, equivalent to 22,600 ppm fluoride, with functionalized tri-calcium phosphate in an alcohol-based modified-rosin varnish. The coating adheres to enamel and dentin, provides extended release of fluoride, calcium, and phosphate for up to 24 hours, promotes enamel remineralization and caries prevention, and mechanically occludes exposed dentinal tubules to relieve tooth hypersensitivity. It is supplied as a unit-dose dental varnish applied in a thin layer to teeth. ([multimedia.3m.com](https://multimedia.3m.com/mws/media/2192221O/ifu-clinpro-white-varnish-we-cee-laapac-v2.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clinpro White Varnish.